relat
proteinas
pro
pro
picornavirus
coronavirus
respect
good
drug
target
part
effort
gener
broadspectrum
inhibitor
enzym
screen
librari
inhibitor
base
halopyridinyl
ester
previou
studi
sever
acut
respiratori
syndrom
sar
proteinas
hepat
viru
hav
pro
three
compound
also
furan
ring
inhibit
cleavag
activ
hav
pro
k
ic
nm
hplcbase
assay
reveal
inhibitor
slowli
hydrolyz
hav
pro
sar
pro
confirm
ident
expect
product
mass
spectrometr
analys
indic
hydrolysi
proceed
via
acylenzym
intermedi
model
studi
indic
halopyridinyl
moieti
inhibitor
fit
tightli
pocket
consist
lack
toler
inhibitor
modif
portion
molecul
compound
among
potent
nonpeptid
inhibitor
report
date
pro
method
white
solid
h
nmr
cdcl
mhz
ddd
j
hz
dd
j
hz
j
hz
j
hz
j
hz
ddt
j
hz
dd
j
hz
ddd
j
hz
hrm
ei
calcd
c
h
cl
found
method
white
solid
h
nmr
cdcl
mhz
br
dd
regul
proteolysi
critic
featur
process
viral
polyprotein
essenti
replic
proteinas
constitut
import
target
novel
antivir
main
proteinas
respons
process
picornavirus
coronavirus
proteinas
pro
pro
respect
picornavirus
includ
import
human
pathogen
human
rhinoviru
hrv
polioviru
pv
hepat
viru
hav
well
signific
insect
plant
agricultur
pathogen
footandmouth
diseas
viru
fmdv
coronavirus
includ
etiolog
agent
sever
acut
respiratori
syndrom
sar
outbreak
given
signific
viral
pathogen
intens
effort
underway
develop
novel
antivir
compound
target
pro
pro
crystal
structur
hav
pro
first
solv
picornavir
proteinas
overal
fold
resembl
twodomain
bbarrel
fold
chymotrypsin
cystein
activ
site
typic
proteinas
activ
site
consist
long
groov
two
bbarrel
domain
enzym
specif
determin
residu
line
groov
central
portion
groov
two
domain
lie
conserv
residu
catalyt
triad
nucleophil
gener
acidbas
catalyst
form
hydrogen
bond
catalyt
triad
consist
pro
structur
identifi
date
includ
pv
hrv
fmdv
coronavir
pro
similar
twodomain
bbarrel
fold
third
ahel
domain
play
role
dimer
contribut
activ
site
pocket
coronavirus
activ
site
cyshi
catalyt
dyad
type
proteinas
catalyt
mechan
similar
follow
bind
substrat
latter
carbonyl
carbon
atom
scissil
peptid
bond
subject
nucleophil
attack
sulfur
atom
activ
site
cy
format
tetrahedr
intermedi
stabil
residu
electrophil
oxyanion
hole
loss
amid
lead
format
acyl
enzym
intermedi
catalysi
complet
follow
deacyl
restor
activ
site
except
peptidyl
aldehyd
peptidyl
fluoromethyl
keton
mani
inhibitor
hav
pro
develop
date
particularli
potent
initi
bind
enzym
ketoglutamin
analogu
well
studi
potenti
inhibitor
analogu
phthalhydrazid
moieti
display
initi
competit
revers
inhibit
hav
pro
best
k
lm
longer
period
hour
alkyl
activ
site
cystein
thiol
concomit
loss
phthalhydrazid
moieti
compound
improv
cycliz
glutamin
side
chain
result
inhibitor
ic
low
micromolar
rang
lall
et
al
also
investig
interact
blacton
hav
found
revers
inhibitor
k
lm
interestingli
enantiomer
compound
irrevers
inhibitor
k
inact
k
min
given
similar
activ
site
architectur
pro
pro
expect
proteinas
inhibit
similar
class
compound
inde
may
possibl
gener
broadspectrum
inhibitor
enzym
screen
librari
small
molecul
reveal
pyridinyl
thiophen
ester
tabl
inhibit
sar
pro
ic
lm
compound
also
inhibit
hav
pro
essenti
ident
ic
recent
librari
heteroaromat
ester
base
creat
screen
sar
pro
potent
ester
tabl
inhibit
proteinas
ic
nm
mass
spectrometr
analysi
suggest
mechan
inhibit
involv
acyl
enzym
furoyl
group
slow
reactiv
enzym
suggest
acylenzym
subject
deacyl
enzym
catalyz
slow
hydrolysi
ester
herein
investig
abil
heteroaromat
ester
inhibit
hav
pro
inhibitor
screen
hav
pro
use
fluoresc
peptid
substrat
steadyst
inhibit
paramet
potent
inhibitor
evalu
mode
action
inhibitor
investig
use
hplcbase
kinet
assay
mass
spectrometr
analys
result
studi
compar
inhibit
sar
pro
heteroaromat
ester
well
previous
describ
hav
pro
inhibitor
librari
pyridinyl
ester
scheme
yield
potent
inhibitor
sar
coronovir
proteinas
screen
hav
pro
picornavir
enzym
use
micropl
assay
compound
complet
inhibit
proteinas
activ
test
lm
show
complet
inhibit
lm
none
show
complet
inhibit
lm
tabl
six
compound
tabl
inhibit
proteinas
activ
greatest
extent
lm
ic
valu
assess
ic
experi
perform
describ
initi
screen
except
substrat
concentr
lm
use
summar
tabl
six
compound
ic
rang
nm
lm
lowest
valu
close
theoret
minim
valu
determin
experi
ie
concentr
enzym
studi
use
suffici
pyridinyl
ester
complet
inhibit
initi
hydrolysi
fluorogen
peptid
hav
pro
peptid
hydrolysi
sometim
observ
incub
reaction
mixtur
min
suggest
hav
pro
might
catalyz
slow
hydrolysi
ester
inhibitor
investig
possibl
develop
hplcbase
assay
monitor
inhibitor
hydrolysi
hav
pro
sar
pro
reaction
perform
use
concentr
pyridinyl
ester
high
enough
ensur
enzym
satur
hplc
analysi
reaction
mixtur
demonstr
expect
hydrolysi
product
could
observ
timedepend
manner
concomit
disappear
ester
fig
hydrolysi
depend
enzym
test
ester
product
identif
confirm
possibl
comparison
known
standard
assay
perform
sever
concentr
ester
confirm
satur
proteinas
ester
enzymat
hydrolysi
rate
correct
nonenzymat
hydrolysi
inhibitor
calcul
deduc
steadyst
kinet
paramet
three
best
inhibitor
summar
tabl
k
cat
valu
calcul
hydrolysi
rate
satur
ester
concentr
k
valu
taken
equival
determin
k
ic
valu
case
substrat
slowli
turn
eg
seah
et
al
among
three
inhibitor
test
hav
pro
two
acyl
group
similar
k
cat
valu
equival
studi
use
sar
pro
potent
inhibitor
demonstr
proteinas
also
catalyz
ester
hydrolysi
paramet
similar
observ
hav
pro
kinet
data
indic
hav
pro
catalyz
slow
hydrolysi
pyridinyl
ester
inhibitor
investig
whether
hydrolysi
proce
via
acylenzym
intermedi
sampl
proteinas
incub
min
lm
result
sampl
analyz
mass
spectrometri
shown
figur
incub
hav
pro
result
mass
increas
da
consist
coval
attach
furoyl
moieti
w
da
departur
leav
group
sampl
incub
min
acyl
form
proteinas
detect
gain
insight
interact
inhibitor
hav
pro
prior
acyl
compound
computermodel
activ
site
pocket
enzym
dock
complex
obtain
use
program
autodock
best
bind
mode
judg
bind
energi
allow
bond
length
angl
one
halopyridin
ring
occupi
pocket
fig
specif
nitrogen
halopyridinyl
ring
hydrogen
bond
n
halogen
atom
point
toward
solvent
carbonyl
oxygen
ester
locat
oxyanion
hole
enzym
form
two
hydrogen
bond
n
distanc
respect
studi
target
librari
compound
screen
identifi
sever
potent
inhibitor
picornavir
hav
pro
six
potent
inhibitor
contain
ester
bond
connect
halopyridin
ring
ring
tabl
potent
competit
inhibit
hydrolysi
peptidyl
substrat
k
ic
nm
among
lowest
inhibitor
pro
enzym
report
date
hplc
mass
spectrometr
analysi
demonstr
ester
slow
substrat
hav
pro
hydrolysi
proceed
via
acylenzym
intermedi
consist
mechan
involv
ratelimit
deacyl
two
compound
possess
acyl
group
similar
k
cat
valu
interestingli
halopyridinyl
ester
better
substrat
hav
pro
peptid
substrat
character
date
exampl
k
cat
k
valu
versu
acelrtqsfsnh
due
enzym
except
low
k
valu
halopyridinyl
ester
eg
nm
consider
lower
good
peptid
substrat
mm
acelrtqsfsnh
contrast
enzym
turn
peptid
substrat
much
effici
k
cat
acelrtqsfsnh
versu
importantli
specif
viral
proteinas
natur
polypeptid
substrat
yet
determin
presenc
ester
linkag
critic
featur
effect
inhibit
pro
test
small
molecul
exampl
compound
lack
ester
bond
poor
inhibitor
suggest
compound
interact
proteinas
particularli
strongli
comparison
inhibit
characterist
ester
reveal
flexibl
cyclic
acid
moieti
ester
pyridinyl
alcohol
exampl
moder
inhibit
hav
pro
concentr
lm
despit
differ
size
cyclic
acid
moieti
cyclic
acid
moieti
subject
constraint
illustr
compound
constraint
difficult
deduc
current
data
set
space
ester
alcohol
acid
moieti
also
critic
alcohol
acid
compound
good
inhibitor
despit
possess
two
addit
carbon
atom
ch
ch
acid
side
ester
respect
contrast
insert
singl
addit
carbon
atom
ch
alcohol
side
ester
potent
inhibitor
yield
poor
inhibitor
final
presenc
posit
halogen
pyridin
ring
import
determin
inhibit
posit
ring
nitrogen
respect
ester
bond
thu
compound
contain
poor
inhibitor
similarli
compound
lack
halogen
substitu
vs
substitu
ortho
para
es
ter
group
vs
also
poor
inhibitor
overal
result
indic
halopyridin
ring
particularli
import
determin
inhibit
model
dock
hav
pro
consist
structureact
relationship
inhibitor
particular
model
indic
halopyridinyl
ring
essenti
fill
pocket
enzym
pyridin
nitrogen
atom
form
hydrogen
bond
n
pocket
fig
contrast
consider
space
enzym
activ
site
around
furan
ring
although
model
hav
pro
complex
clarifi
role
halogen
group
pyridin
ring
group
possibl
halogen
influenc
electron
characterist
andor
solvat
pyridinyl
ring
enhanc
inhibit
model
hav
pro
complex
also
consist
hydrolysi
ester
compound
via
acylenzym
intermedi
two
aspect
first
distanc
c
carbonyl
carbon
second
two
atom
almost
coplanar
imidazol
ring
therefor
ideal
posit
n
act
gener
base
normal
enzymat
hydrolysi
peptidyl
substrat
scissil
peptid
bond
expect
line
spatial
orient
cy
catalyt
pair
activ
site
howev
model
hav
pro
complex
show
rather
differ
direct
central
scissil
ester
bond
compound
primarili
due
predict
strong
propens
bromopyridinyl
ring
bind
insid
pocket
interestingli
similar
bind
mode
predict
complex
sar
pro
group
pyridinyl
esterbas
inhibitor
consid
similar
picornavir
pro
coronavir
pro
surpris
librari
pyridinyl
ester
yield
similar
potent
inhibitor
hav
sar
proteinas
particular
enzym
catalyt
driven
cyshi
pair
high
specif
gln
residu
specif
reflect
similar
pocket
especi
histidin
base
sar
pro
hav
pro
respect
import
determin
specif
enzym
consist
similar
predict
bind
mode
halopyridinyl
ester
sar
similar
predict
hav
pro
halopyridinyl
moieti
occupi
pocket
ring
acid
moieti
extend
pocket
screen
librari
nonpeptid
inhibitor
includ
previous
describ
hav
pro
character
detail
sever
potent
inhibitor
inhibitor
previous
shown
potent
inhibit
relat
sar
pro
abil
halopyridinyl
ester
inhibit
two
diverg
pro
strongli
suggest
compound
could
use
inhibit
relat
proteinas
coronavirus
picornavirus
fmdv
hrv
inhibitor
might
improv
increas
specif
presum
target
pocket
better
slow
enzymat
hydrolysi
inde
given
correl
turnov
ester
k
cat
nonenzymat
stabil
halflif
decreas
enzymat
hydrolysi
might
improv
stabil
aqueou
solut
final
given
slightli
differ
substratebind
pocket
differ
pro
comparison
inhibit
relat
proteinas
seri
halopyridinyl
ester
might
provid
insight
mode
substrat
bind
physicochem
properti
substratebind
pocket
determin
excel
specif
enzym
factor
x
purchas
hematolog
technolog
inc
essex
junction
usa
peptid
synthes
nucleic
acid
protein
servic
unit
univers
british
columbia
confirm
mass
spectrometr
analysi
chemic
analyt
grade
use
without
purif
two
gener
procedur
use
prepar
pyridinyl
ester
method
follow
compound
ad
solut
carboxyl
acid
mmol
equiv
dmf
ml
rt
edci
mg
mmol
equiv
hobt
mg
mmol
equiv
dipea
mmol
equiv
pyridinol
mg
mmol
equiv
h
stir
solvent
remov
vacuo
afford
crude
mixtur
method
b
follow
compound
ad
solut
carboxyl
acid
mmol
equiv
dcm
ml
rt
thionyl
chlorid
ml
equiv
catalyt
amount
dmf
drop
h
stir
solvent
remov
vacuo
afford
acyl
chlorid
product
solut
acyl
chlorid
dcm
ml
ad
dropwis
solut
pyridinol
mg
mmol
equiv
pyridin
ml
equiv
dcm
ml
h
stir
solvent
remov
vacuo
afford
crude
mixtur
crude
mixtur
purifi
use
hplc
coupl
esmsd
agil
posit
ion
detect
hplc
fit
semiprepar
column
zorbax
mm
lm
equip
guard
column
column
oper
flow
rate
mlmin
compound
elut
use
linear
gradient
acetonitril
formic
acidh
min
follow
acetonitril
formic
acidh
min
final
return
acetonitril
formic
acidh
min
qualiti
select
purifi
sampl
confirm
reinject
sampl
analyt
column
zorbax
mm
lm
oper
flow
rate
mlmin
use
abovedescrib
linear
gradient
hav
pro
produc
heterolog
use
escherichia
coli
plyss
contain
substitut
nonessenti
surfac
cystein
residu
variant
prevent
intermolecular
disulfid
bond
format
freshli
transform
cell
grown
overnight
lb
broth
supplement
lgml
ampicillin
lgml
chloramphenicol
use
inocul
one
litr
medium
cultur
grown
optic
densiti
nm
approxim
whereupon
heterolog
gene
express
induc
ad
mm
iptg
cell
incub
h
harvest
centrifug
wash
use
mm
potassium
phosphat
ph
contain
mm
edta
mm
dtt
frozen
use
purifi
hav
pro
frozen
cell
resuspend
ml
mm
potassium
phosphat
mm
edta
mm
dtt
ph
disrupt
use
french
press
oper
psi
cell
debri
remov
centrifug
min
supernat
pass
lm
filter
filter
cell
extract
load
onto
mono
column
preequilibr
mm
potassium
phosphat
mm
edta
ph
oper
mlmin
kta
explor
ge
healthcar
proteinas
elut
use
gradient
mm
nacl
ml
equilibr
buffer
eight
millilit
fraction
collect
contain
proteinas
judg
sdspage
combin
concentr
use
stir
cell
concentr
equip
membran
amicon
etobicok
canada
protein
solut
concentr
mgml
frozen
bead
liquid
nitrogen
sixti
milligram
pro
typic
obtain
one
liter
cell
cultur
histag
sar
pro
produc
purifi
describ
previous
except
histag
remov
remov
histag
protein
exchang
three
time
mm
tri
ph
amend
mm
nacl
mm
ca
histag
remov
proteolyt
use
factor
x
w
w
overnight
concentr
protein
load
onto
monoq
column
preequilibr
mm
tri
ph
protein
elut
gradient
mm
nacl
ml
equilibr
buffer
fraction
contain
proteinas
combin
exchang
mm
tri
ph
concentr
mgml
frozen
bead
liquid
nitrogen
yield
mg
pro
obtain
l
cell
cultur
steadyst
proteolyt
activ
hav
pro
sar
pro
measur
use
fluorogen
peptid
substrat
dabcylglrtqsnd
edan
g
abzsvtlqsgi
r
respect
standard
assay
perform
use
potassium
phosphat
ph
mm
edta
contain
lm
proteinas
lm
peptid
initi
inhibitor
screen
ic
determin
hav
pro
done
use
plate
victor
fluoresc
plate
reader
perkinelm
woodbridg
canada
substrat
lm
inhibitor
lm
prewarm
three
minut
black
micropl
total
volum
reaction
start
addit
enzym
k
ex
nm
k
em
nm
determin
k
done
use
varian
eclips
fluoresc
spectrophotomet
varian
cari
nc
usa
assay
perform
use
quartz
cuvett
k
ex
nm
k
em
nm
sar
pro
k
ex
nm
k
em
nm
sar
pro
initi
rate
calcul
use
first
min
progress
curv
correct
inner
filter
effect
describ
liu
et
al
use
snd
edan
g
abzsvtlq
appropri
steadyst
equat
fit
initialr
data
use
leastsquar
dynam
weight
option
leonora
rate
pyridinyl
ester
hydrolysi
determin
monitor
product
format
use
hplc
assay
perform
hplc
vial
contain
potassium
phosphat
ph
mm
edta
lm
proteinas
lm
pyridinyl
ester
reaction
initi
addit
ester
aliquot
withdrawn
analyz
use
water
separ
modul
equip
phenomenex
prodigi
l
odprep
column
water
photodiod
array
detector
column
oper
flow
rate
mlmin
develop
use
follow
threestep
profil
ml
acetonitril
formic
acidh
ml
linear
gradient
acetonitril
formic
acidh
ml
acetonitril
rate
calcul
first
hour
reaction
enzymat
rate
correct
nonenzymat
hydrolysi
sampl
hav
pro
prepar
react
lm
enzym
lm
pyridinyl
ester
mm
potassium
phosphat
buffer
ph
mm
edta
min
sampl
quench
acet
acid
submit
nap
malditof
analysi
autom
molecular
dock
perform
use
program
autodock
recent
structur
model
hav
pro
pdb
target
structur
ester
compound
construct
use
sybyl
tripo
inc
st
loui
usa
inhibitorenzym
interact
evalu
use
lamarckian
genet
algorithm
lga
bind
energi
compound
protein
evalu
use
grid
map
point
space
gener
use
autogrid
program
default
valu
dock
paramet
use
except
follow
step
size
translat
orient
torsion
number
gener
energi
evalu
dock
run
dock
inhibitorenzym
complex
rank
accord
lowest
predict
bind
energi
conform
ideal
geometri
dock
structur
